Another example involves the use of rabbit anti-thymocyte globulin and alemtuzumab, which have been given to organ transplant patients to counteract acute rejection; however, this treatment can induce a substantial decline in the number of CD4+ T cells and thus increase the risk of cryptococcal infection [18]. Here, CD4 is linked to cryptococcosis.